Introduction to Drug Development
DPET 830. Introduction to Drug Development (2)
Prerequisites
PY3 status or Permission of Instructor.
Description
Discussions include preclinical drug safety evaluation, preclinical pharmacology, design of protocols for Phases I-IV, FDA guidelines for clinical study, preparation of study plan, statistics in clinical trials, data analysis, and FDA interactions with industry.
Availability
Fall
Course Type
Graduate Course, PharmD Course